Xcout Intel
Gate Bioscience
Gate Bioscience is a biotechnology company headquartered in Brisbane, California, creating a new class of small molecule therapeutics known as Molecular Gates for targeted protein elimination.
Subscribe to see Gate Bioscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gate Bioscience at a glance
Gate Bioscience is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $65M in November 2025. Xcout tracks 14 named people at Gate Bioscience, including Brian Cathers (Chief Scientific Officer).
Gate Bioscience leadership
- Brian CathersChief Scientific Officer
- Jordi Mata-FinkChief Executive Officer Co-Founder
- Raman TalwarChief Technology Officer Co-Founder
- Pat SharpScientific Founder
- Danielle AubeleVP, Medicine Design
- David WyattVP, Discovery Sciences
8 more named people on record for Gate Bioscience, with roles, board committees and tenure — see the full roster →
Gate Bioscience funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $65M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Gate Bioscience competitors
A few of Gate Bioscience's closest competitors — see the full list of competitors and alternatives →
Cleave Biosciences, Inc. is a biotechnology research company headquartered in California, focused on discovering and developing novel therapies that target protein homeostasis to treat cancer.
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
Lycia Therapeutics, Inc. is a leader in extracellular protein degradation, headquartered in South San Francisco, California.
Cullgen Inc. is a biotechnology company based in San Diego, California, that powers protein degradation for tomorrow's medicines.
Neomorph is a clinical-stage biotechnology company founded in 2020 and headquartered in San Diego, California. The company pioneers the discovery and development of molecular glue degraders to target and destroy difficult disease-causing proteins.
Get Gate Bioscience's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Gate Bioscience in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access